SCHEMBL6919006

SCHEMBL6919006

CCCCOC(C(=O)OC)C(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
ALDH1A1 P00352 1/20 0.46
ZDHHC7 Q9NXF8 1/20 0.46
ATM Q13315 1/20 0.43
MAPT P10636 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ACHE P22303 7/20 0.41
TSHR P16473 2/20 0.41
HPGD P15428 1/20 0.41
NPC1 O15118 1/20 0.40
CASP1 P29466 1/20 0.40
RAB9A P51151 1/20 0.40
EPHX1 P07099 1/20 0.39
LMNA P02545 1/20 0.39
ESR1 P03372 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13928730 0.92 ZDHHC7 (0.52) CA1CA2ZDHHC7ACHETSHR
SCHEMBL26844566 0.83 CA1 (0.48) CA1CA2ALDH1A1ZDHHC7ATM
SCHEMBL446324 0.81 CA1 (0.47) CA1CA2ALDH1A1ZDHHC7ATM
SCHEMBL12309039 0.81 CA1 (0.47) CA1CA2ALDH1A1ZDHHC7ATM
SCHEMBL9515904 0.81 CA1 (0.47) CA1CA2ALDH1A1ZDHHC7ATM
SCHEMBL27710499 0.79 GAA (0.38) CA1CA2ALDH1A1ZDHHC7MAPT
SCHEMBL12626100 0.78 ABCB1 (0.50) CA1CA2ALDH1A1ZDHHC7ATM
SCHEMBL8942342 0.77 SMN1; SMN2 (0.37) CA1CA2ALDH1A1ZDHHC7ACHE
SCHEMBL31637531 0.77 SMN1; SMN2 (0.37) CA1CA2ALDH1A1ZDHHC7TSHR
SCHEMBL27976884 0.77 ALDH1A1 (0.50) ALDH1A1ATMTSHRHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462123-B1 4,5,6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS MERCK SHARP & DOHME (US) 2013-10-02 EP disclosed
US-20120136016-A1 4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS MERCK SHARP & DOHME LLC 2012-05-31 US disclosed
WO-2011017296-A1 4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136016-A1 4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS F9, F8, F12 CA1 2685/4885CA2 2649/4885ALDH1A1 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.